| SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures |
2022-06-22 |
| Abound Bio–Galapagos: investment, 202206 acquisition $14m in cash of AboundBio by Galapagos |
2022-06-21 |
| CellPoint–Galapagos: investment, 202206 acquisition in cash €125m upfront + €100m milestones of CellPoint by Galapagos |
2022-06-21 |
| CH-Bioforce–EU (govt): grant, 202206– EIC Accelerator programme grant up to €15m to advance biomass processing plant |
2022-06-21 |
| ProtonDx–SciTribe: public relations, 202206 service existent by SciTribe |
2022-06-21 |
| Elypta–Bonnier: investment, 202206 financing round Series A totalling $21m incl lead investor Bonnier Ventures |
2022-06-20 |
| Elypta–Chalmers Univ: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Chalmers Ventures |
2022-06-20 |
| Elypta–Hillclimber: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Hillclimber |
2022-06-20 |
| Elypta–Nina Capital: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Nina Capital |
2022-06-20 |
| Elypta–Norrsken Foundation: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Norrsken VC |
2022-06-20 |
| Elypta–SEVERAL: investment, 202206 financing round Series A $21m led by Bonnier Ventures |
2022-06-20 |
| Elypta–Sweden (govt): investment, 202206 financing round Series A totalling $21m incl existing + co-investor Industrifonden |
2022-06-20 |
| Elypta–Wallenberg: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Navigare Ventures |
2022-06-20 |
| Kranus Health–A Round Capital: investment, 202206 financing round Series A totalling >$6.5m incl existing + co-investor A Round Capital |
2022-06-20 |
| Kranus Health–High-Tech Gründerfonds: investment, 202206 financing round Series A totalling >$6.5m incl existing + co-investor HTGF |
2022-06-20 |
| Kranus Health–Karista: investment, 202206 financing round Series A totalling >$6.5m incl lead investor Karista |
2022-06-20 |
| Kranus Health–Peak Pride: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Peak Pride |
2022-06-20 |
| Kranus Health–PERSON: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Ehsan Khaljani |
2022-06-20 |
| Kranus Health–PERSON: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Florian Brand |
2022-06-20 |
| Kranus Health–Saarbruecker21: investment, 202206 financing round Series A totalling >$6.5m incl co-investor business angel group Saarbruecker21 |
2022-06-20 |
| Kranus Health–SEVERAL: investment, 202206 financing round Series A >$6.5m led by Karista |
2022-06-20 |
| High-Tech Gründerfonds–SEVERAL: investment, 202206 1st closing of HTGF IV at more than €400m incl BMWK + KfW Capital |
2022-06-14 |
| JnJ–Evotec: drug discovery services, 202206– collab discover novel mode of action drugs using TargetAlloMod platforms for Janssen Pharmaceutica |
2022-06-14 |
| Spirea–ACF Investors: investment, 202206 financing round totalling £2.4m incl co-investor ACF Investors |
2022-06-14 |
| Spirea–Cambridge Angels: investment, 202206 financing round totalling £2.4m incl co-investor Cambridge Angels |
2022-06-14 |
| Spirea–Meltwind: investment, 202206 financing round totalling £2.4m incl existing + co-lead investor Jonathan Milner |
2022-06-14 |
| Spirea–o2h: investment, 202206 financing round totalling £2.4m incl existing + co-investor o2h Ventures |
2022-06-14 |
| Spirea–R42 Group: investment, 202206 financing round totalling £2.4m incl co-investor R42 Group |
2022-06-14 |
| Spirea–SEVERAL: investment, 202206 financing round £2.4m led by Jonathan Milner + Cambridge Enterprise |
2022-06-14 |
| Spirea–SyndicateRoom: investment, 202206 financing round totalling £2.4m incl existing + co-investor Syndicate Room |
2022-06-14 |
| Spirea–Univ Cambridge: investment, 202206 financing round totalling £2.4m incl existing + co-lead investor Cambridge Enterprise |
2022-06-14 |
| ImCheck Therapeutics–SEVERAL: investment, 202206 financing round Series C €80m co-led by new investors Earlybird + Andera Partners |
2022-06-13 |
| Charm Therapeutics–Axial: investment, 202206 financing round Series A totalling $50m incl co-investor Axial |
2022-06-09 |
| Charm Therapeutics–Braavos Investment Advisers: investment, 202206 financing round Series A totalling $50m incl co-investor Braavos |
2022-06-09 |
| Charm Therapeutics–Consilium: public relations, 202206 service existent by Consilium Strategic Communications |
2022-06-09 |
| Charm Therapeutics–F-Prime: investment, 202206 financing round Series A totalling $50m incl co-lead investor F-Prime Capital |
2022-06-09 |
| Charm Therapeutics–General Catalyst: investment, 202206 financing round Series A totalling $50m incl co-investor General Catalyst |
2022-06-09 |
| Charm Therapeutics–Khosla Ventures: investment, 202206 financing round Series A totalling $50m incl co-investor Khosla Ventures |
2022-06-09 |
| Charm Therapeutics–OrbiMed: investment, 202206 financing round Series A totalling $50m incl co-lead investor OrbiMed |
2022-06-09 |
| Charm Therapeutics–SEVERAL: investment, 202206 financing round Series A $50m co-led by F-Prime Capital + OrbiMed |
2022-06-09 |
| Forbion–SEVERAL: investment, 202206 first close €470m of Forbion Growth Opportunities Fund II with target size of €600m hard cap |
2022-06-09 |
| Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners |
2022-06-09 |
| Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital |
2022-06-09 |
| Peptone–Hoxton Ventures: investment, 202206 financing round Series A totalling $40m incl existing + co-investor Hoxton Ventures |
2022-06-09 |
| Peptone–Novartis: investment, 202206 financing round Series A totalling $40m incl existing + co-investor dRX Capital |
2022-06-09 |
| Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine |
2022-06-09 |
| Peptone–SEVERAL: investment, 202206 financing round Series A $40m led by F-Prime + Bessemer Venture Partners |
2022-06-09 |
| Peptone–Walden Catalyst: investment, 202206 financing round Series A totalling $40m incl co-investor Walden Catalyst Vemtures |
2022-06-09 |
| Relation Therapeutics–SEVERAL: investment, 202206 seed financing round $25m co-led by DCVC + Magentic Ventures |
2022-06-09 |
| Ariceum Therapeutics–Bellevue: investment, 202206 financing round Series A totalling €25m incl co-investor Pureos Bioventures |
2022-06-08 |
| Ariceum Therapeutics–EQT: investment, 202206 financing round Series A totalling €25m incl co-founding + co-lead investor EQT Life Sciences |
2022-06-08 |
| Ariceum Therapeutics–Odlander Fredrikson: investment, 202206 financing round Series A totalling €25m incl co-founding + co-lead investor HealthCap |
2022-06-08 |
| Ariceum Therapeutics–Optimum Strategic Communications: public relations, 202206 service existent by Optimum |
2022-06-08 |
| Ariceum Therapeutics–SEVERAL: investment, 202206 financing round Series A €25m co-led by HealthCap + EQT Life Sciences |
2022-06-08 |
| BioVersys–SEVERAL: investment, 202206 financing round Series C first closing CHF24.2m from existing + new investors |
2022-06-08 |
| Frame Cancer Therapeutics–CureVac: investment, 202206 acquisition in shares €32m with €16m upfront + €16m milestones |
2022-06-08 |
| Synklino–Denmark (govt): investment, 202206 financing round Series A totallling €29.8m incl existing + co-investor Vaekstfonden |
2022-06-08 |
| Synklino–Eir Ventures: investment, 202206 financing round Series A totallling €29.8m incl existing + co-investor Eor Vemtures |
2022-06-08 |
| Synklino–Maj Invest: investment, 202206 financing round Series A totallling €29.8m incl new + co-investor Maj Invest |
2022-06-08 |
| Synklino–Optimum Strategic Communications: public relations, 202206 service existent by Optimum |
2022-06-08 |
| Synklino–PKA: investment, 202206 financing round Series A totallling €29.8m incl new + lead investor PKA Pension Fund |
2022-06-08 |
| Synklino–SEVERAL: investment, 202206 financing round Series A €29.8m (DKK222m) led by PKA Pension Fund |
2022-06-08 |
| CimCure–Intravacc: cancer vaccine, 202206 collab existent developm + production of lead compound of CimCure |
2022-06-07 |
| CimCure–PERSON: investment, 202206 seed financing round totalling €5m incl co-investor investment vehicle of Tom Würdinger |
2022-06-07 |
| CimCure–Positron Ventures: investment, 202206 seed financing round totalling €5m incl lead investor Positron Ventures |
2022-06-07 |
| CimCure–SEVERAL: investment, 202206 seed financing round €5m led by Positron Ventures |
2022-06-07 |
| ImmunOs Therapeutics–BioMedPartners: investment, 202206 financing round Series B totalling $74m incl existing + co-investor BioMedPartners |
2022-06-07 |
| ImmunOs Therapeutics–Fiscus Financial: investment, 202206 financing round Series B totalling $74m incl new + co-investor Fiscus Financial |
2022-06-07 |
| ImmunOs Therapeutics–Gimv: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Gimv |
2022-06-07 |
| ImmunOs Therapeutics–GL Capital: investment, 202206 financing round Series B totalling $74m incl new + co-investor GL Capital |
2022-06-07 |
| ImmunOs Therapeutics–Lightspeed Venture Partners: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Lightspeed VP |
2022-06-07 |
| ImmunOs Therapeutics–Mission BioCapital: investment, 202206 financing round Series B totalling $74m incl new + co-investor Mission BioCapital |
2022-06-07 |
| ImmunOs Therapeutics–Peak6 Strategic Capital: investment, 202206 financing round Series B totalling $74m incl new + co-investor Peak6 |
2022-06-07 |
| ImmunOs Therapeutics–Pfizer: investment, 202206 financing round Series B totalling $74m incl existing + co-investor Pfizer Ventures |
2022-06-07 |
| ImmunOs Therapeutics–Samsara BioCapital: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Samsara BioCapital |
2022-06-07 |
| ImmunOs Therapeutics–Schroders: investment, 202206 financing round Series B totalling $74m incl existing + co-investor Schroder Adveq |
2022-06-07 |
| ImmunOs Therapeutics–SEVERAL: investment, 202206 financing round Series B $74m led by Samsara BioCapital + Lightspeed VP + Gimv |
2022-06-07 |
| Vizgen–SEVERAL: investment, 202206 financing round Series C $85.2m co-led by Blue Water Life Science + ARCH Venture Partners |
2022-06-03 |
| Vizgen–Sofina: investment, 202206 financing round Series C totalling $85.2m incl co-investor Sofina |
2022-06-03 |
| BMS–Immatics: cancer immunotherapy, 202201– collab strategic alliance expansion $60m upfront + $700 milestones per programme using ACTallo platform |
2022-06-02 |
| Merck (DE)–Proxygen: molecular glue degraders, 202206– strategic multi-year collab + license agreem up to €495m plus royalties |
2022-06-02 |
| Transition Bio–SEVERAL: investment, 202206 financing round Series A $50m led by Northpond Ventures |
2022-06-02 |
| Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD |
2022-06-01 |
| Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance |
2022-06-01 |
| Affinivax–GSK: investment, 202205– acquisition 100% for $2.1b upfront + $1.2b milestones by GSK ANNOUNCED |
2022-05-31 |
| Firmenich–DSM: investment, 202205– merger with former DMS owners holding 65.5% + Firmenich owners receiving 34.5% plus €3.5b in cash ANNOUNCED |
2022-05-31 |
| Minoryx–Columbus Venture Partners: investment, 202205 financing round Series C incl co-lead investor Columbus Venture Partners |
2022-05-31 |
| Minoryx–Fund+: investment, 202205 financing round Series C incl existing + co-investor Fund+ |
2022-05-31 |
| Minoryx–la Caixa: investment, 202205 financing round Series C incl existing + co-lead investor Caixa Capital Risc |
2022-05-31 |
| Minoryx–SEVERAL: credit, 202205 complementary bank debt to Series C financing round (both tog totalling €51m) |
2022-05-31 |
| Minoryx–SEVERAL: investment, 202205 financing round Series C (incl complementary bank totalling €51m) led by Columbus VP + Caixa Capital Risc |
2022-05-31 |
| Minoryx–Spain (govt): investment, 202205 financing round Series C incl new + co-investor CDTI Innvierte |
2022-05-31 |
| Minoryx–Ysios Capital: investment, 202205 financing round Series C incl existing + co-investor Ysios Capital |
2022-05-31 |
| Repertoire Genesis–Eurofins: investment, 202205 acquisition of majority stake by Eurofins Scientific |
2022-05-31 |
| Transine Therapeutics–Epidarex Capital: investment, 202205 seed financing round expansion totalling £4.6m incl new + lead investor Epidarex |
2022-05-31 |
| Transine Therapeutics–SEVERAL: investment, 202205 seed financing round expansion £4.6m led by Epidarex bringing total seed round to £13.7m |
2022-05-31 |
| Transine Therapeutics–SV Health Investors: investment, 202205 seed financing round expansion totalling £4.6m incl existing + co-investor DDF |
2022-05-31 |
| Ultima Genomics–aMoon: investment, 202205 emerges from stealth with $600m incl investor aMoon |
2022-05-31 |
| Ultima Genomics–PERSON: investment, 202205 emerges from stealth with $600m incl investor Marius Nacht |
2022-05-31 |
| Ultima Genomics–SEVERAL: investment, 202205 emerges from stealth with $600m raised from leading life science investors |
2022-05-31 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220401-650-100-promote-brand-to-decision-makers.jpg)
Date![Picture [iito] No Tracking 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-tracking.jpg){kind=tracking}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
